Skip to main content
×
Home

n-3 Fatty acids, cancer and cachexia: a systematic review of the literature

  • Ramón Colomer (a1), José M. Moreno-Nogueira (a2), Pedro P. García-Luna (a3), Pilar García-Peris (a4), Abelardo García-de-Lorenzo (a5), Antonio Zarazaga (a6), Luis Quecedo (a7), Juan del Llano (a7), Luis Usán (a8) and César Casimiro (a8)...
Abstract

Use of n-3 fatty acids (FA) has been reported to be beneficial for cancer patients. We performed a systematic review of the literature in order to issue recommendations on the clinical use of n-3 FA in the cancer setting. A systematic search was performed in MEDLINE, EMBASE, Cochrane and Healthstar databases. We selected clinical trials or prospective observational studies including patients with cancer and life expectancy >2 months, in which enteral supplements with n-3 FA were administered. Parameters evaluated individually were clinical (nutritional status, tolerance, survival and hospital stays), biochemical (inflammatory mediators), and functional (functional status, appetite and quality of life (QoL)). Seventeen studies met the inclusion criteria; eight were of high quality. The panel of experts established the following evidence: (1) oral supplements with n-3 FA benefit patients with advanced cancer and weight loss, and are indicated in tumours of the upper digestive tract and pancreas; (2) the advantages observed were: increased weight and appetite, improved QoL, and reduced post-surgical morbidity; (3) there is no defined pattern for combining different n-3 FA, and it is recommended to administer >1·5 g/day; and (4) better tolerance is obtained administering low-fat formulas for a period of at least 8 weeks. All the evidences were grade B but for ‘length of treatment’ and ‘advantage of survival’ it was grade C. Our findings suggest that administration of n-3 FA (EPA and DHA) in doses of at least 1·5 g/day for a prolonged period of time to patients with advanced cancer is associated with an improvement in clinical, biological and QoL parameters.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      n-3 Fatty acids, cancer and cachexia: a systematic review of the literature
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      n-3 Fatty acids, cancer and cachexia: a systematic review of the literature
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      n-3 Fatty acids, cancer and cachexia: a systematic review of the literature
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Dr. Ramón Colomer, fax +34 972 206723, email rcolomer@icogirona.scs.es
References
Hide All
Barber MD, Ross JA, Voss AC, Tisdale MJ & Fearon KC (1999 a) The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. British Journal of Cancer 81(1), 8086.
Barber MD, Ross JA, Preston T, Shenkin A & Fearon KC (1999 b) Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. Journal of Nutrition 129(6), 11201125.
Barber MD, McMillan DC, Preston T, Ross JA & Fearon KC (2000) Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by fish-oil-enriched nutritional supplement. Clinical Science 98, 389399.
Barber MD, Fearon KC, Tisdale MJ, McMillan DC & Ross JA (2001 a) Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutrition & Cancer 40(2), 118124.
Barber MD & Fearon KC (2001 b) Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia. Lipids 36(4), 347351.
Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G & Baracos V (2003) Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. Journal of Clinical Oncology 21(1), 129134.
Burns CP, Halabi S, Clamon GH, Hars V, et al. (1999) Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukaemia group B. Clinical Cancer Research 5, 39423947.
Burns P, Halabi S, Clamon G, Kaplan E, et al. (2004) Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. A Cancer and Leukemia Group B study. Cancer 101, 370378.
Elia M, Van Bokhorst-de van der Schueren MA, Garvey J, Goedhart A, Lundholm K, Nitenberg G & Stratton RJ (2006) Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. International Journal of Oncology 28(1), 523.
Fearon KC, Von Meyenfeldt MF, Moses AG, et al. (2003) Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomized double blind trial. Gut 52(10), 14791486.
Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC & Kalfarentzos F (1998) Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 82(2), 395402.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Renolds JM, Gavaghan DJ & McQuay HJ (1996) Assessing the quality of reports on randomized clinical trials: Is blinding necessary? Controlled Clin Trials 17, 112.
Jatoi A, Rowland K, Loprinzi CL, Sloan JA, et al. (2004) An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 22, 24692476.
Jovell JA & Navarro Rubio MD (1995) Evaluación de la evidencia científica. Med Clin 105, 2629.
Karmali R (1996) Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia. Nutrition 12, S2S4.
Kelley DS (2001) Modulating of human immune and inflammatory responses by dietary fatty acids. Nutrition 17, 669673.
Kenler AS, Swails WS, Driscoll DF, et al. (1996) Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Annals of Surgery 223(3), 316333.
Meydani S (1996) Effects of (n-3) polyunsaturated fatty acids on cytokine production and their biological function. Nutrition 12, S8S14.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D & Stroup DF (1999) Improving the quality of randomised controlled trials meta-analyses reports: the QUOROM statement. Quality of reporting Meta-analyses. Lancet 354(9193), 18961900.
Moses AWG, Slater C, Preston T, Barber MD & Fearon KC (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. British Journal of Cancer 90, 9961002.
Resolution ResAP (2003)3 on food and nutritional care in hospitals..
Roynette CE, Calder P, Dupertuis YM & Pichard C (2004) N-3 polyunsaturated fatty acids and colon cancer prevention. Clin Nutr 23, 139151.
Swails WS, Kenler AS, Driscoll DF, et al. (1997) Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery. Journal of Parenteral & Enteral Nutrition 21(5), 266274.
Vancassel S, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Andres C & Chalon S (2001) Plasma fatty acid levels in autistic children. Prostaglandins Leukotrienes and Essential Fatty Acids 65(1), 17.
Voss AC & Gallagher-Allred C (1996) The importance of outcomes research in documenting the benefit of nutrition intervention. Nutrition 12, 5960.
Wigmore SJ, Ross JA, Falconer JS, et al. (1996) The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12(Suppl. 1), S27S30.
Wigmore SJ, Barber MD, Ross JA, Tisdale MJ & Fearon KC (2000) Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutrition & Cancer 36(2), 177184.
Xia S-H, Wang J & Kang JX (2005) Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by down regulation of cell adhesion/invasion-related genes. Carcinogenesis 26, 779784.
Zuijdgeest-Van Leeuwen SD, Dagnelie PC, Wattimena JL, et al. (2000) Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation. Clinical Nutrition 19(6), 417423.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 22
Total number of PDF views: 356 *
Loading metrics...

Abstract views

Total abstract views: 883 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd November 2017. This data will be updated every 24 hours.